PUTNOE MEDICAL CENTRE PARTNERSHIP — All Prescriptions & Medications — Page 4
Practice Code: E81029 | BEDFORD, MK41 9JE
Showing results 151-200 of 666
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mometasone furoate | 333 | 368 | £2.9K | -17.1% ▼ |
| Lorazepam | 327 | 8,427 | £2.2K | +129.4% ▲ |
| Tirzepatide | 325 | 378 | £37.5K | +67.3% ▲ |
| Timolol | 324 | 11.8K | £3.0K | +266.3% ▲ |
| Carbomer 940/980 | 323 | 7,320 | £1.4K | +112.1% ▲ |
| Sodium valproate | 320 | 45.6K | £5.3K | +0.6% vs avg |
| Fluticasone propionate (Inhalation) | 317 | 471 | £9.8K | -18.1% ▼ |
| Loratadine | 314 | 16.9K | £365 | +50.3% ▲ |
| Cyclizine hydrochloride | 314 | 15.9K | £557 | +94.6% ▲ |
| Estriol | 314 | 5,236 | £5.4K | +47.6% ▲ |
| Lithium carbonate | 313 | 9,264 | £1.7K | +146.7% ▲ |
| Ranolazine | 310 | 28.6K | £5.2K | +82.4% ▲ |
| Brinzolamide | 306 | 2,340 | £1.7K | +135.5% ▲ |
| Chloramphenicol | 304 | 2,472 | £1.4K | +165.5% ▲ |
| Carbamazepine | 298 | 41.6K | £2.5K | +0.4% vs avg |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 289 | 345 | £15.2K | +72.8% ▲ |
| Hyoscine butylbromide | 288 | 23.5K | £1.7K | +23.6% ▲ |
| Biphasic isophane insulin | 283 | 2,448 | £10.7K | +153.7% ▲ |
| Bimatoprost | 282 | 4,542 | £3.8K | +89.7% ▲ |
| Letrozole | 280 | 12.9K | £1.1K | +49.9% ▲ |
| Calcipotriol | 278 | 23.1K | £12.6K | +63.3% ▲ |
| Sacubitril/valsartan | 277 | 21.9K | £35.8K | +15.7% ▲ |
| Azithromycin | 271 | 5,808 | £1.4K | +113.8% ▲ |
| Lisdexamfetamine dimesylate | 270 | 7,017 | £17.6K | +126.1% ▲ |
| Other individually formulated bought in preparations | 270 | 1,108 | £924 | +726.4% ▲ |
| Dexamethasone | 269 | 1,380 | £861 | +56.4% ▲ |
| Clotrimazole | 268 | 1,877 | £2.5K | +142.9% ▲ |
| Ciclosporin (Eye Anti Inflammatory) | 268 | 12.0K | £28.9K | +980.8% ▲ |
| Loperamide hydrochloride | 266 | 18.7K | £509 | +14.2% ▲ |
| Azathioprine | 266 | 18.7K | £418 | +145.4% ▲ |
| 262 | 30.2K | £1.0K | -5.2% ▼ | |
| Co-careldopa (Carbidopa/levodopa) | 261 | 40.0K | £3.5K | +15.5% ▲ |
| Betahistine hydrochloride | 256 | 25.5K | £871 | +7.2% ▲ |
| Nystatin | 253 | 8,730 | £501 | +151.0% ▲ |
| Insulin glargine | 250 | 1,189 | £9.4K | -11.9% ▼ |
| Risedronate sodium | 250 | 1,392 | £378 | +106.1% ▲ |
| Lidocaine hydrochloride | 249 | 2,344 | £3.1K | +44.3% ▲ |
| Chlorphenamine maleate | 247 | 30.1K | £1.9K | +123.8% ▲ |
| Clobetasone butyrate | 247 | 11.1K | £1.2K | +21.0% ▲ |
| Docusate sodium | 246 | 29.5K | £2.3K | -33.6% ▼ |
| Timolol and bimatoprost | 244 | 2,124 | £3.6K | +60.8% ▲ |
| Goserelin acetate | 243 | 255 | £41.9K | +451.6% ▲ |
| Powder extensively hydrolysed formula (0913101) | 240 | 662.0K | £19.2K | +233.1% ▲ |
| Sulfasalazine | 239 | 37.8K | £4.9K | +83.6% ▲ |
| Perindopril erbumine | 228 | 12.3K | £999 | -57.0% ▼ |
| Tadalafil | 224 | 3,506 | £598 | +31.7% ▲ |
| Hydrocortisone acetate | 220 | 6,945 | £1.3K | +233.2% ▲ |
| Moxonidine | 214 | 13.3K | £1.9K | +284.4% ▲ |
| Diltiazem hydrochloride | 212 | 12.9K | £2.7K | -31.0% ▼ |
| Hydrocortisone | 210 | 5,074 | £1.1K | +176.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.